EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Targeting brain‐derived neurotrophic factor in the treatment of neurodegenerative diseases: A review

Dong Wang, Zhi-Chen Lang, Shi-Nan Wei, Wei Wang, Hao Zhang iD

Neuroprotection · 2024-06 · 2 (2) · 67-78

DOI: 10.1002/nep3.43 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Neuroprotection, online erschienen am 02.05.2024. Verfasst von Dong Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Postgraduate Training Base of Jinzhou Medical University (The PLA Rocket Force Characteristic Medical Center) Beijing China. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 154 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurodegenerative diseases, marked by the gradual death of neurons, present a significant and growing public health challenge. Brain‐derived neurotrophic factor (BDNF) is crucial for the survival, development, and synaptic plasticity of neurons. Studies have consistently demonstrated that perturbed BDNF communication pathways are associated with the development and progression of neurodegenerative conditions, underscoring their potential as therapeutic targets. This review aimed to summarize the existing findings regarding BDNF expression, metabolism, and signaling transduction. Furthermore, we reviewed the intricate roles of BDNF signaling pathways in neurodegenerative diseases, elucidating their contributions to disease onset and progression. The latest advancements in targeting BDNF for the treatment of neurodegenerative diseases, including the development of small molecules, nucleic acid‐based therapeutics, and antibody‐based approaches, were also summarized. Despite recent strides, challenges persist, including a lack of comprehensive understanding of BDNF modulation across diverse neurodegenerative contexts and the absence of clinically approved BDNF‐targeted drugs.

Schlagwörter

Stichwörter der Autor:innen

brain‐derived neurotrophic factorcentral nervous systemdrug therapygene therapyneurodegenerative diseasesneuron

Autor:innen und Institutionen

  • The Postgraduate Training Base of Jinzhou Medical University (The PLA Rocket Force Characteristic Medical Center) Beijing China.
  • Department of Anesthesiology The PLA Rocket Force Characteristic Medical Center Beijing China.

ORCID-Profile: Hao Zhang

Zitieren

APA

Wang, D., Lang, Z. C., Wei, S. N., Wang, W., & Zhang, H. (2024). Targeting brain‐derived neurotrophic factor in the treatment of neurodegenerative diseases: A review. Neuroprotection, 2(2), 67-78. https://doi.org/10.1002/nep3.43

Vancouver

Wang D, Lang ZC, Wei SN, Wang W, Zhang H. Targeting brain‐derived neurotrophic factor in the treatment of neurodegenerative diseases: A review. Neuroprotection. 2024;2(2):67-78. doi:10.1002/nep3.43

BibTeX
@article{Wang2024,
  author = {Wang, Dong and Lang, Zhi-Chen and Wei, Shi-Nan and Wang, Wei and Zhang, Hao},
  title = {Targeting brain‐derived neurotrophic factor in the treatment of neurodegenerative diseases: A review},
  journal = {Neuroprotection},
  year = {2024},
  volume = {2},
  number = {2},
  pages = {67--78},
  doi = {10.1002/nep3.43}
}
Kostenlos starten →